Market overview
The global gene synthesis market is worth USD 2.8 bn in 2026 and is forecast to reach USD 11.2 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Gene fragments and clonal genes is the largest by product segment.
| Scope | Custom synthesis of DNA fragments, genes, gene libraries and oligonucleotide pools sold as services and benchtop synthesizers to research, biopharma and synthetic biology customers. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.4 bn |
| Value 2026 | USD 2.8 bn |
| Value 2036 | USD 11.2 bn |
| CAGR 2026-2036 | 15.0% |
| Volume 2026 | 6,229 million base pairs |
| Volume 2036 | 37,905 million base pairs |
| Average price 2026 | USD 0.44 per base pair |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Gene Synthesis market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 2.8 bn |
| 2027 | USD 3.2 bn |
| 2028 | USD 3.7 bn |
| 2029 | USD 4.2 bn |
| 2030 | USD 4.8 bn |
| 2031 | USD 5.6 bn |
| 2032 | USD 6.4 bn |
| 2033 | USD 7.3 bn |
| 2034 | USD 8.4 bn |
| 2035 | USD 9.7 bn |
| 2036 | USD 11.2 bn |
Gene Synthesis market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Gene fragments and clonal genes | 52.0% | 45.7% | USD 1.4 bn | 13.5% |
| Oligonucleotide pools and libraries | 23.0% | 26.2% | USD 635 mn | 16.5% |
| Long and complex constructs | 15.0% | 15.7% | USD 414 mn | 15.5% |
| Synthesizers and enzymatic kits | 10.0% | 12.4% | USD 276 mn | 17.5% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharma and biotech | 44.0% | 47.9% | USD 1.2 bn | 16.0% |
| Academic and research institutes | 28.0% | 21.5% | USD 773 mn | 12.0% |
| Diagnostics and CROs | 14.0% | 14.0% | USD 386 mn | 15.0% |
| Industrial and agricultural biotech | 14.0% | 16.6% | USD 386 mn | 17.0% |
By technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Phosphoramidite chemical synthesis | 64.0% | 50.0% | USD 1.8 bn | 12.2% |
| Enzymatic synthesis | 14.0% | 30.0% | USD 386 mn | 24.1% |
| Microarray-based synthesis | 22.0% | 20.0% | USD 607 mn | 13.9% |
By gene length
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 500 base pairs | 36.0% | 32.0% | USD 994 mn | 13.7% |
| Mid length | 40.0% | 40.0% | USD 1.1 bn | 15.0% |
| Long constructs | 24.0% | 28.0% | USD 662 mn | 16.8% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Therapeutic and vaccine development | 32.0% | 33.0% | USD 883 mn | 15.3% |
| Synthetic biology and protein engineering | 28.0% | 30.0% | USD 773 mn | 15.8% |
| Diagnostics | 14.0% | 14.0% | USD 386 mn | 15.0% |
| Basic research | 26.0% | 23.0% | USD 718 mn | 13.6% |
Top 25 countries for gene synthesis by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 97.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.2 bn | 42.0% | USD 4.4 bn | 14.2% |
| 2 | China | USD 386 mn | 14.0% | USD 2.2 bn | 19.2% |
| 3 | Germany | USD 193 mn | 7.0% | USD 670 mn | 13.2% |
| 4 | United Kingdom | USD 166 mn | 6.0% | USD 569 mn | 13.2% |
| 5 | Japan | USD 138 mn | 5.0% | USD 435 mn | 12.2% |
| 6 | France | USD 110 mn | 4.0% | USD 380 mn | 13.2% |
| 7 | Switzerland | USD 83 mn | 3.0% | USD 290 mn | 13.4% |
| 8 | Canada | USD 83 mn | 3.0% | USD 313 mn | 14.2% |
| 9 | South Korea | USD 83 mn | 3.0% | USD 368 mn | 16.1% |
| 10 | India | USD 69 mn | 2.5% | USD 368 mn | 18.2% |
| 11 | Netherlands | USD 21 mn | 0.8% | USD 84 mn | 14.8% |
| 12 | Australia | USD 21 mn | 0.8% | USD 84 mn | 14.8% |
| 13 | Singapore | USD 18 mn | 0.7% | USD 90 mn | 17.6% |
| 14 | Denmark | USD 18 mn | 0.7% | USD 73 mn | 15.0% |
| 15 | Spain | USD 15 mn | 0.5% | USD 60 mn | 15.0% |
| 16 | Italy | USD 15 mn | 0.5% | USD 60 mn | 15.0% |
| 17 | Sweden | USD 15 mn | 0.5% | USD 60 mn | 15.0% |
| 18 | Belgium | USD 15 mn | 0.5% | USD 60 mn | 15.0% |
| 19 | Israel | USD 15 mn | 0.5% | USD 60 mn | 15.0% |
| 20 | Brazil | USD 12 mn | 0.4% | USD 60 mn | 17.6% |
| 21 | Taiwan | USD 12 mn | 0.4% | USD 48 mn | 15.0% |
| 22 | Ireland | USD 12 mn | 0.4% | USD 48 mn | 15.0% |
| 23 | Austria | USD 8.8 mn | 0.3% | USD 36 mn | 15.0% |
| 24 | Finland | USD 8.8 mn | 0.3% | USD 36 mn | 15.0% |
| 25 | Norway | USD 8.8 mn | 0.3% | USD 36 mn | 15.0% |
| Rest of world | USD 75 mn | 2.7% | USD 288 mn | 14.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Twist Bioscience
- GenScript
- Integrated DNA Technologies
- Thermo Fisher Scientific
- Eurofins Genomics
- Azenta Life Sciences
- Sangon Biotech
- Merck KGaA
Group 2: Regional and specialist players
- Telesis Bio
- Ansa Biotechnologies
- Ribbon Biolabs
- Tsingke Biotechnology
- ATUM
- Synbio Technologies
- OriGene Technologies
- Bio Basic
- Biomatik
- Eton Bioscience
Group 3: Emerging and niche players
- Elegen
- DNA Script
- Evonetix
- Moligo Technologies
- Camena Bioscience
- Molecular Assemblies
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the gene synthesis market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.
The market is divided by product, by end user, by technology, by gene length, by application. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the gene synthesis market?
The global gene synthesis market is estimated at USD 2.4 bn in 2025 and USD 2.8 bn in 2026.
How fast will the gene synthesis market grow?
It is forecast to reach USD 11.2 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 8.4 bn.
Which country is the largest market for gene synthesis?
United States is the largest market by revenue at USD 1.2 bn in 2026, 42.0% of the global total. The three largest countries together hold 63.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 19.2% a year from 2026 to 2036.
Which gene synthesis segment is largest?
In the by product split, Gene fragments and clonal genes is the largest segment with 52.0% of 2026 revenue.
Who are the leading gene synthesis companies?
Global leaders include Twist Bioscience, GenScript, Integrated DNA Technologies, Thermo Fisher Scientific.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Laboratory Information Management SystemUSD 2.7 bn · 9.5% CAGR
- 3D Cell CultureUSD 2.7 bn · 12.0% CAGR
- CRISPR and Cas GeneUSD 2.9 bn · 13.5% CAGR
- Chromatography ResinUSD 2.6 bn · 9.8% CAGR
- Cardiovascular Drug DiscoveryUSD 2.6 bn · 7.5% CAGR
- Tangential Flow FiltrationUSD 2.5 bn · 9.0% CAGR
- Spray DryingUSD 3.0 bn · 5.3% CAGR
- Enzyme Linked Immunosorbent AssayUSD 3.1 bn · 5.2% CAGR